New York State Common Retirement Fund’s Acumen Pharmaceuticals ABOS Stock Holding History

New York State Common Retirement Fund’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,800	Closed	-$10.8K	–	3198
2025 Q1	$10.8K	Hold	9,800	–	–	﹤0.01%	3072
2024 Q4	$16.9K	Hold	9,800	–	–	﹤0.01%	3067
2024 Q3	$24.3K	Sell	9,800 -32,600	-77%	-$88.4K	﹤0.01%	3017
2024 Q2	$103K	Buy	+42,400	New	+$135K	﹤0.01%	2788
2022 Q3	–	Sell	-257	Closed	-$1K	–	3254
2022 Q2	$1K	Sell	257 -23,724	-99%	-$89.1K	﹤0.01%	3305
2022 Q1	$94K	Buy	23,981 +18,500	+338%	+$101K	﹤0.01%	3032
2021 Q4	$37K	Buy	+5,481	New	+$60.2K	﹤0.01%	3264

Other funds holding ABOS

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KIA

Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

New York State Common Retirement Fund's ABOS Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Acumen Pharmaceuticals (ABOS) in Q2 2025, closing a stake of 9,800 shares — an estimated $10.8K sold.

New York State Common Retirement Fund first reported a position in ABOS in Q4 2021 and held it in 7 quarters. The position peaked at $103K in Q2 2024. 71 funds tracked by Wall St. Rank hold ABOS as of Q2 2025.

New York State Common Retirement Fund reported no remaining Acumen Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
New York State Common Retirement Fund sold 9,800 Acumen Pharmaceuticals shares in Q2 2025, an estimated $10.8K.
New York State Common Retirement Fund first reported a position in Acumen Pharmaceuticals in Q4 2021 and held it in 7 quarters.
New York State Common Retirement Fund's Acumen Pharmaceuticals position peaked at $103K in Q2 2024.
71 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.